Actively Recruiting
Observational Study Characterizing Acute Respiratory Infections in Emergency and Acute Hospital Care Settings Across Europe
Led by European Clinical Research Alliance for Infectious Diseases (ECRAID) · Updated on 2026-10-29
11750
Participants Needed
27
Research Sites
N/A
Total Duration
AI-Summary
What This Trial Is About
Researchers are studying acute respiratory infections ARI, which are common reasons for hospital admissions and antibiotic use. This study aims to describe the diagnostic and treatment practices, as well as clinical outcomes, for both adult and pediatric patients with ARI who present to emergency rooms and acute hospital settings across Europe. The study focuses on understanding the causes of ARI and how current diagnostic methods and treatments are used in routine care. Participants include adults 18 years and older and children under 18 years who present with suspected new episodes of ARI. The study collects detailed data on diagnostic methods, including laboratory and point-of-care tests, as well as treatments such as antibiotics and antivirals. A subset of participants will provide upper respiratory tract samples for molecular pathogen detection within 24 hours of enrollment. Data is gathered for both admitted patients and those discharged on the same day. Throughout the study, researchers collect clinical, laboratory, and prescribing information using standardized forms. They monitor patient outcomes such as microbiology investigations, medication use, length of hospital or ICU stay, respiratory support duration, and mortality up to 28 days after admission or discharge. The study will run for several years, providing comprehensive data on ARI management and outcomes in European acute care settings.
CONDITIONS
Brief Title
POS-ARI-ER Observational Study of Acute Respiratory Infections
Research Team
J
Jake Dunning
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here